Leadership

Meet our leadership team

The leaps we’re helping to deliver in research and innovation that inform better patient outcomes wouldn’t be possible without our deep partnerships with researchers and clinicians across all sectors of the healthcare landscape including: university, pharma, community health, and more.

QLHC Operations

The daily operational leadership who make our leaps against cancer possible.

James Palazzolo

CEO

Karyn Digiorgio

Chief Collaboration Officer

Adam Asare

Chief Data Officer

Radhika Sivaramakrishna

Senior Vice President, Clinical Operations & Compliance

Pinaki Chakraborty

Vice President, Quality Assurance

Vice President, Statistics

Imogene M. Dunn Phd

Kathryn Watson-Feiner

Vice President, Finance and Administration

Smita Asare

Exec Director, I - SPY Phase 1

Sara Horton

Executive Director, Access & Diversity

Keyhan Afaghi

Senior Director, Quality Assurance

Paul Henderson

Senior Director,Collaborations

Philip Beineke

Director of Biometrics, Oncology

Susan Colen

Director, BreastCancerTrials

Jacqueline Murray

Director, Marketing & Communications

Ami Okada

Director, I - SPY COVID Trial

Maria Pitsiouni

Director, Clinical Operations Oncology

Muhammed Salem

Director, Clinical Safety

QLHC Board of Directors

Laura Esserman

MD, MBA | Cofounder

Jeffrey Pfeffer

MD, MBA | Cofounder

Dave Mandelkern

MS | Chairman of the Board

Anna Barker

PHD

Lucas de Breed

PhD, MBA

Susan Foley

CFA

Michele Markus

MS | Chairman of the Board

Robert Patterson

Esq

Gregory C. Simon

Mark Simon

MBA

N. Marcus Thygeson

MD, MPH

Lambert van der Walde

MBA

Robyn Lawrie Rutledge

PhD, MBA

Your financial support of any amount can
help make a huge leap in our efforts to
deliver personalized medicine for all.

© Quantum Leap Healthcare Collaborative. 2023-2024.